สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์
Printed on 20 March 2025 09:12

Publication Document

Please enter search criteria
Document Type
Issuer / Underlying / Securities
Date From
To
 Reset

DOD BIOTECH PUBLIC COMPANY LIMITED : DOD

The Financial Statements which need to be revised ( 0 record(s) found)
Order DateCompany NameReviewed Financial Statement Details
Data not found
Finanacial Statements ( 56 record(s) found)
NameYearStatusTypePeriodAs OfDetails
DOD BIOTECH PUBLIC COMPANY LIMITED2024AuditedConsolidatedYear31/12/2024
DOD BIOTECH PUBLIC COMPANY LIMITED2024AuditedCompanyYear31/12/2024
DOD BIOTECH PUBLIC COMPANY LIMITED2024ReviewedConsolidatedQ330/09/2024
DOD BIOTECH PUBLIC COMPANY LIMITED2024ReviewedCompanyQ330/09/2024
DOD BIOTECH PUBLIC COMPANY LIMITED2024ReviewedConsolidatedQ230/06/2024
DOD BIOTECH PUBLIC COMPANY LIMITED2024ReviewedCompanyQ230/06/2024
DOD BIOTECH PUBLIC COMPANY LIMITED2024ReviewedConsolidatedQ131/03/2024
DOD BIOTECH PUBLIC COMPANY LIMITED2024ReviewedCompanyQ131/03/2024
DOD BIOTECH PUBLIC COMPANY LIMITED2023AuditedConsolidatedYear31/12/2023
DOD BIOTECH PUBLIC COMPANY LIMITED2023Audited (Restatement)ConsolidatedYear31/12/2023
Click here to display all results
Key Financial Ratio ( 0 record(s) found)
NameBusiness TypeTypePeriodYearAs OfDetails
Data not found
Management's Discussion and Analysis ( 13 record(s) found)
DateTimeHeadingLink
19/02/202518:35Management Discussion and Analysis Yearly Ending 31 Dec 2024
07/11/202417:51Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024
08/08/202421:28Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
09/05/202420:48Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024
23/02/202408:41Management Discussion and Analysis Yearly Ending 31 Dec 2023
08/11/202319:33Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023
11/08/202308:33Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023
11/05/202321:36Management Discussion and Analysis Quarter 1 Ending 31 Mar 2023
22/02/202317:37Management Discussion and Analysis Yearly Ending 31 Dec 2022
15/11/202220:07Management Discussion and Analysis Quarter 3 Ending 30 Sep 2022 (Revised)
Click here to display all results
SEC has ordered to amend Finanacial Statements ( 0 record(s) found)
NameDescriptionDetails
Data not found
Last updated on 19 March 2025